Ubs Group Ag Horizon Therapeutics Public LTD CO Call Options Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	SELL	$98.98 - $115.74 $133 Million - $155 Million	-1,341,500 Reduced 94.53%	77,700 $8.99 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $136 Million - $159 Million	1,412,700 Added 21733.85%	1,419,200 $146 Million
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $7.67 Million - $8.12 Million	-71,500 Reduced 91.67%	6,500 $709,000
Q4 2022 Feb 08, 2023	BUY	$62.39 - $113.8 $4.87 Million - $8.88 Million	78,000 New	78,000 $8.88 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.